• GSK3 Inhibition and Intracellular M. tuberculosis

  2026-09-07

  The reference study identifies host glycogen synthase kinase 3 as a controllable determinant of intracellular Mycobacterium tuberculosis growth. By combining pharmacological screening, CRISPR and RNAi perturbation, macrophage models, and phosphoproteomics, it provides a mechanistic rationale for GSK3-directed host-directed therapy rather than relying only on direct-acting antibiotics.

• ECM1 Epitope LA as a Dual-Immune Tumor Vaccine

  2026-09-07

  Yu et al. identified the HLA-A2.1-restricted ECM1-derived epitope LA as a candidate therapeutic tumor vaccine that activates both CD8+ T cells and NK cells through dendritic-cell cross-activation. The study combines epitope discovery, cellular immunology, molecular pathway analysis, and humanized tumor models to provide a mechanistic proof of concept, while also defining important limits for translation beyond HLA-matched systems.

• EdU Flow Cytometry Assay Kits (Cy3): S-Phase Insights

  2026-09-05

  EdU Flow Cytometry Assay Kits (Cy3) connect direct S-phase DNA synthesis measurement with mechanistic cancer biology. This guide shows how the K1077 workflow can help test proliferation hypotheses arising from the ESCO2 pan-cancer study while preserving multiplexing flexibility.

• Z-WEHD-FMK: Inflammatory Caspase Research

  2026-09-04

  Z-WEHD-FMK, also named Z-Trp-Glu(OMe)-His-Asp(OMe)-FMK, is a cell-permeable irreversible inhibitor used to investigate inflammatory caspase signaling. Its reported applications include caspase-dependent pyroptosis, Chlamydia-associated Golgi fragmentation, inflammation research, and infectious disease research.

• From TNBC Metabolism to 3X FLAG Validation

  2026-09-04

  The MAZ–BCKDK–G6PD axis offers a compelling model of metabolic control in triple-negative breast cancer. This thought-leadership article translates those findings into a rigorous recombinant-protein validation strategy, showing how the 3X (DYKDDDDK) Peptide can support detection, affinity workflows, interaction studies, and structural decision-making without overstating what the cancer study itself demonstrated.

• CCK-8 for Cardiomyocyte Senescence Studies

  2026-09-03

  Learn how Cell Counting Kit-8 (CCK-8) can anchor viability and proliferation measurements in cardiomyocyte senescence research. This guide explains how to interpret WST-8 signals alongside mitochondrial, senescence, and cGAS-STING evidence rather than treating metabolism as a standalone proxy for cell number.

• Alpha-Ketoglutarate: A Causal Assay Framework

  2026-09-03

  Explore how alpha-ketoglutarate and α-KGA connect TCA-cycle flux, nitrogen handling, and macrophage antigen presentation. This article develops a compartment-aware assay framework that moves beyond metabolite measurement toward causal interpretation in metabolic reprogramming research.

• Chlorpromazine HCl: Mechanism and Research Use

  2026-09-02

  Chlorpromazine HCl is a phenothiazine dopamine receptor antagonist used in neuropharmacology studies and psychotic disorder research. Its documented receptor activity, assay-range guidance, solubility profile, and potential use as an endocytic-pathway perturbant support controlled in vitro workflows, but nanoparticle uptake findings from electrical stimulation cannot be attributed to chlorpromazine without direct testing.

• Asiaticoside, TGF-β1, and Peritoneal Fibrosis

  2026-09-02

  Zhao et al. showed that asiaticoside suppresses TGF-β1-induced mesothelial-mesenchymal transition and oxidative stress in HMrSV5 human peritoneal mesothelial cells. The study links these effects to reduced Smad signaling and activation of the Nrf2/HO-1 antioxidant pathway, providing a mechanistic framework for investigating peritoneal fibrosis during dialysis.

• Proteinase K Workflows for DNA and Protease Assays

  2026-09-01

  Proteinase K combines broad protein digestion with compatibility across EDTA, SDS, and diverse buffers, making it useful for genomic DNA isolation and enzyme contaminant removal. Its role as a selectivity comparator in SARS-CoV-2 3CLpro screening also shows how a robust protease control can strengthen biochemical assay design.

• Staurosporine Workflows for Apoptosis Research

  2026-09-01

  Staurosporine combines potent, broad kinase inhibition with a practical apoptosis workflow for calibrating cell-death responses and studying post-death tumor-cell states. This guide connects dose–time optimization with metastasis, signaling, and angiogenesis assays while emphasizing controls that prevent overinterpreting a nonspecific kinase tool.

• Capsazepine: A Better Pain Assay Strategy

  2026-08-31

  Capsazepine is a TRPV1 ion channel antagonist whose value extends beyond simple capsaicin blockade. This guide presents an orthogonal assay strategy that separates TRPV1 biology from calcium-current, TRPM8, and apoptosis-related effects.

• Polyethylenimine Linear in Translational Biology

  2026-08-31

  A mechanistic and strategic guide to using Polyethylenimine Linear (PEI), MW 40,000 for transient gene expression, HEK-293 transfection, and disease-model development inspired by emerging evidence on H3K18 lactylation, NOD2, and astrocyte pyroptosis.

• Macromolecular Cryoprotection for Assay-Ready THP-1 Cells

  2026-08-30

  A 2025 RSC Applied Polymers study shows that polyampholyte cryoprotectants and controlled ice nucleation can improve post-thaw recovery and differentiation of THP-1 monocytes in both vials and multi-well plates. By linking cryo-Raman evidence of reduced intracellular ice with functional macrophage readouts, the work advances the prospect of assay-ready immune-cell banking.

• Tetramethylrhodamine Ethyl Ester Perchlorate Guide

  2026-08-29

  Use Tetramethylrhodamine ethyl ester perchlorate to convert mitochondrial membrane potential into a live-cell fluorescence readout for microscopy, flow cytometry, and plate-based assays. Its greatest value is functional: it complements ROS, apoptosis, and protein-level measurements by showing whether mitochondria remain electrically polarized during injury or recovery.

7983 records 6/533 page Previous Next First page 上5页 678910 下5页 Last page